![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 10, 8716-8723, March 8, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania 15261
Received for publication, October 25, 2001, and in revised form, December 14, 2001
| |
ABSTRACT |
|---|
|
|
|---|
Repair of DNA interstrand cross-links is a
challenging problem for cells. Many human gene products influence
sensitivity to DNA cross-linking agents, but the mechanisms of
cross-link repair are unknown. In Drosophila melanogaster,
the mus308 mutation leads to marked sensitivity to DNA
cross-linking agents. The C-terminal portion of the Mus308 polypeptide
encodes a DNA polymerase, whereas a putative DNA helicase is encoded by
the N-terminal portion. As a step toward isolating proteins involved in
DNA cross-link repair, we searched for mammalian genes similar to the
DNA helicase portion of Mus308. Human and mouse homologs were isolated
from cDNA expression libraries and designated HEL308.
Human HEL308 is on chromosome 4q21 and encodes a
polypeptide of 1101 amino acids. The protein was expressed in insect
cells and purified. HEL308 is a single-stranded
DNA-dependent ATPase and DNA helicase. Mutation of a highly
conserved lysine to methionine in helicase domain I eliminated both
activities. The protein readily displaces 20- to 40-mer duplex
oligonucleotides. Displacement of longer substrates was less efficient
but was stimulated by the single-stranded DNA-binding protein RPA.
Activity was supported by ATP or dATP but not other nucleotide
triphosphates. The enzyme translocates on DNA with 3' to 5' polarity
and behaves as a multimer upon gel filtration.
DNA interstrand cross-linking agents such as nitrogen mustards,
mitomycin C, and psoralen are widely used in cancer chemotherapy because of their high cytotoxicity to dividing cells (1). A single
unrepaired interstrand cross-link
(ICL)1 can kill a bacterial
or yeast cell, and about 40 unrepaired ICLs can kill a mammalian cell
(2, 3). Moreover, DNA ICLs induce mutations and chromosomal
rearrangements. The most extensive studies of cross-link repair have
been carried out in Escherichia coli, in which the major
interstrand cross-link repair pathway is well characterized, both
genetically and biochemically. ICL repair in eukaryotes is less well
understood, and there may be several pathways (4). In E. coli and in Saccharomyces cerevisiae, the repair of
ICLs depends on both nucleotide excision repair and homologous
recombination (5-7). In mammals, mutant cell lines sensitive to
cross-linking agents have been useful to identify proteins that might
be involved in ICL repair. XPF and ERCC1 mutant cell lines, in addition to being defective in nucleotide excision repair, are particularly sensitive to cross-linking agents (8), suggesting that these proteins play a special role in ICL repair. Similarly, mutations in the XRCC2 and XRCC3
genes, encoding proteins with sequence homology to the human RAD51
protein, confer sensitivity to cross-linking agents (9). Fanconi anemia
cell lines are also particularly susceptible to such agents. Thus far,
eight Fanconi anemia complementation groups have been defined, and six genes have been mapped and cloned, FANCA, FANCC, FANCD2, FANCE, FANCF, and FANCG (1). Studying Fanconi anemia will
likely be of great value in understanding human ICL repair mechanisms,
but the function of the FANC proteins is still unclear.
In Drosophila melanogaster, mutations in the
mus308 gene lead to marked sensitivity to cross-linking
agents. Experiments suggested that some incision event takes place in
mus308 mutants, but full repair does not take place (10).
The C-terminal portion of the Mus308 protein encodes a DNA polymerase,
whereas the N-terminal portion encodes the seven characteristic motifs
found in DNA and RNA helicases (11). Sharief et al. (12)
cloned a human cDNA for POLQ, encoding a polypeptide
homologous to the Mus308 polymerase domain but with no corresponding
helicase region. A longer cDNA sequence for human POLQ,
deposited with the NCBI data base by Abbas and Linn (NCBI
accession number NM_006596, predicts a presumably full-length protein
with the polymerase domain in the C-terminal portion and a helicase
domain at the N terminus, similar to D. melanogaster Mus308.
In many DNA repair pathways, the function of DNA helicases
is essential. In particular, UvrD helicase is needed to repair ICLs in
E. coli (13). Moreover, defects in DNA helicases are the
causes of several human diseases. BLM and WRN, the products of the
Bloom and Werner syndrome genes, are members of the RecQ family of DNA
helicases (14, 15). Although their most critical roles in cells are not
precisely known, they participate in pathways of DNA damage tolerance.
Another member of the RecQ family of helicases, RECQ4, has been
implicated in a subset of cases of Rothmund-Thompson syndrome (16). XPD
and XPB helicases, two of the subunits of TFIIH transcription/repair
factor, are involved in nucleotide excision repair (17), and mutations
in their genes can lead to the disorders xeroderma pigmentosum and trichothiodystrophy.
With the aim of isolating new proteins implicated in DNA cross-link
repair, we sought mammalian homologs of the putative helicase portion
of D. melanogaster Mus308. We report identification of new
human and mouse genes and the biochemical activity of the human
gene product.
Cloning of Human and Mouse HEL308--
Human and mouse
HEL308 genes were cloned by 3' and 5' rapid
amplification of cDNA ends using a CLONTECH
SMART RACE cDNA Amplification kit. Primers were designed from human
expressed sequence tags AA625285, H08004, and R24580 in order to clone
the full human HEL308 coding region. cDNA was prepared
from the testis cancer cell line 833K and the bladder cancer cell line
MGH-U1 (18) according to the manufacturer's instructions
(CLONTECH). Two fragments of 1767 bp (3' RACE) and
2167 bp (5' RACE) were combined to obtain the entire HEL308
coding region. The mutant HEL308K365M gene was
generated with the QuikChange site-directed mutagenesis kit
(Stratagene); the single AAA to ATG (lysine to methionine) substitution
was confirmed by sequencing. Primers were designed from mouse expressed
sequence tag AA517170 to clone mouse Hel308 by RACE PCR from
mouse leukemia L1210 cells RNA (19) and mouse total liver RNA (Ambion
Inc.) using a CLONTECH SMART RACE cDNA Amplification kit.
Purification of Human HEL308--
The human HEL308
open reading frame was subcloned into plasmid pFastBac HTb, and the
Bac-to-Bac baculovirus expression system (Invitrogen) was used
to obtain recombinant baculovirus to infect Sf9 cells. A 500-ml
spinner flask of Sf9 cells (1 × 106/ml) was
infected with the His6-HEL308 baculovirus (multiplicity of
infection of 2) for 48 h at 27 °C. Cells were lysed in 20 ml of
Buffer A (0.15 M Tris, pH 8.0, 0.15 M KCl, 1 mM phenylmethylsulfonyl fluoride, 10% glycerol, 0.5%
Nonidet P-40, EDTA-free protease inhibitor mixture from Roche
Diagnostics) for 30 min on ice. Insoluble material was removed by
centrifugation (22,000 × g for 15 min). KCl was added
to raise the salt concentration to 0.3 M. The extract (12.2 mg/ml) was incubated overnight at 4 °C with 5 ml of
Ni2+-nitrilotriacetate superflow resin (Qiagen). The resin
was washed with 5 column volumes of Buffer A plus 20 mM
imidazole, and the protein was eluted with 20 ml (4 column volumes) of
100 mM imidazole. After reducing the salt concentration to
0.1 M with 10% (v/v) glycerol, the eluate was loaded onto
a Mono Q column, HR 5/5 (AKTA design system, Amersham
Biosciences, Inc.) equilibrated with Buffer C (20 mM
Hepes-KOH, pH 8.0, 1 mM EDTA, 10% glycerol, 1 mM dithiothreitol, 0.01% Nonidet P-40) containing 0.1 M KCl. The column was washed with 1 column volume of
equilibration buffer, and HEL308 protein was eluted with a 20-column
volume linear gradient from 0.1 to 0.5 M KCl in Buffer C. HEL308 presence in the eluted fractions was detected by ATPase and
helicase activities and by immunoblotting. Active fractions eluting
from 0.275 to 0.425 M KCl were pooled, dialysed into Buffer
C containing 0.1 M KCl, and loaded onto a Mono S column, HR
5/5 (AKTA design system, Amersham Biosciences, Inc.) equilibrated with
Buffer C containing 0.1 M KCl. The column was washed with 1 column volume of equilibration buffer, and HEL308 protein was eluted
with a 20-column volume linear gradient from 0.1 to 0.3 M
in Buffer C. Active fractions eluting from 0.125 to 0.20 M
KCl were pooled and dialysed into Buffer C containing 0.1 M
KCl. Protein concentration was determined with the Coomassie Plus
Protein Assay Reagent Kit (Pierce).
For analysis by gel filtration, 200 µl of fraction number 28 from the
Mono Q elution (~0.3 M KCl) was loaded onto a Superose TM
6 HR 10/30 column (AKTA design system, Amersham Biosciences, Inc.)
equilibrated in Buffer C without Nonidet P-40 and containing 0.5 M KCl. Protein was eluted with 1.5 column volumes of the
same buffer at a flow rate of 0.5 ml/min, and 0.5-ml fractions were analyzed by immunoblotting, ATPase, and helicase assays. A calibration curve was prepared by measuring the elution volumes of molecular weight
standards using a Gel Filtration Calibration Kit (Amersham Biosciences,
Inc.).
ATPase Assay--
Standard reaction mixtures (10 µl)
contained: 50 mM KCl, 20 mM Tris-HCl, pH 7.5, 4 mM MgCl2, 1 mM dithiothreitol, 50 µg/ml bovine serum albumin, 0.1 mM cold ATP, 0.25 µCi
[ DNA Helicase Assay--
Partially double-stranded DNA
substrates were generated by annealing oligonucleotides to M13mp18
viral DNA (New England Biolabs). Sequences of the oligonucleotides used
were as follows: 20-mer, 5'-GGTCGACTCTAGAGGATCCC; 24-mer,
CGCCAGGGTTTTCCCAGTCACGAC; 40-mer, GCATGCCTGCAGGTCGACTCTAGAGGATCCCCGGGTACCG; 40-mer + 3'-tail, same sequence as 40-mer plus a non-complementary stretch of
(A)10 at its 3'-end; 40-mer + 5'-tail, same sequence as
40-mer plus a non-complementary stretch of (A)10 at its
5'-end; 60-mer,
AGCTTGCATGCCTGCAGGTCGACTCTAGAGGATCCCCGGGTACCGAGCTCGAATTCGTAA; 70-mer,
TGTAAAACGACGGCCAGTGCCAAGCTTGCATGCCTGCAGGTCGACTCTAGAGGATCCCCGGGTACCGAGC. The gel-purified oligonucleotides were 5'-end-labeled using T4 polynucleotide kinase and [ Accession Numbers--
The GenBankTM
accession number of D. melanogaster mus308 is
L76559. The human POLQ NCBI accession number is NM_006596.
The mus1 homolog from Caenorhabditis elegans
spans cosmids U50184 and U00066 (GenBankTM/EBI accession
numbers). The Arabidopsis thaliana homolog is on cosmid
AL022537 (GenBankTM/EBI accession number).
Isolation of the Human and Mouse HEL308 Genes--
With the aim of
isolating proteins involved in DNA cross-link repair, we searched data
bases with the DNA helicase portion of Drosophila mus308. We
found three human expressed sequence tags, AA625285, H08004, and R24580
(NCBI accession numbers), homologous to motif VI of the D. melanogaster mus308 helicase domain. From this ~700-bp sequence,
primers were designed to clone the whole gene by 3' and 5' rapid
amplification of cDNA ends (CLONTECH SMART RACE
cDNA Amplification kit). Total RNA was prepared from a testis
cancer cell line (833K) and a bladder cancer cell line (MGH-U1). Two
different amplification reactions were performed for each cell line,
and in both cases, two fragments of 1767 and 2167 bp were amplified
through 3' RACE and 5' RACE, respectively. Six different PCR products
(three from the 3' RACE and three from the 5' RACE) were sequenced to
exclude mistakes obtained by PCR amplification. Finally, the complete
open reading frame (3303 bp) was constructed by subcloning the 5'- and
3'-fragments into NcoI and KpnI sites of plasmid
pFastBac HTb. To reflect the helicase activity described below and the
high homology to mus308, we designated the previously
unannotated gene as HEL308.
The human HEL308 gene maps on chromosome 4q21 and encodes
for a protein of 1101 amino acids with a predicted molecular
size of 124.5 kDa. We also found a mouse expressed sequence tag (NCBI accession number AA517170) that allowed us to clone mouse
Hel308 by 3' and 5' rapid amplification of cDNA ends.
Mouse Hel308 maps on chromosome 5-E in a region that is
syntenic to human 4q21.
Human and mouse proteins share 88.6% identity and 93.5% similarity in
the region shown in Fig. 1, and they
belong to the "superfamily II" of DNA and RNA helicases. We aligned
human and mouse HEL308 to D. melanogaster Mus308, C. elegans MUS-1 (3), human POLQ, and the A. thaliana
homolog that we found in the data base (Fig. 1). These proteins share
~50% similarity, and they fall into the group of helicases
designated by Harris et al. (11) as the MUS308 subfamily.
Over the helicase domain region, Drosophila Mus308 has 40%
identity (55% similarity) with HEL308 and 50% identity (66%
similarity) with human POLQ. Human POLQ and human HEL308 share 40%
identity (55% similarity) over the same region. No other human
sequences were found approaching these high levels of homology to the
Drosophila Mus308 helicase domain.
Purification of the Human HEL308 Protein--
The
HEL308 open reading frame was cloned into plasmid pFastBac
HTb, linked to a hexahistidine tag at the N-terminal end. We also generated a cDNA expression construct encoding a tagged
version of HEL308 with a single amino acid substitution at position
365. This conserved lysine residue is in the putative Walker A
nucleotide binding motif and was changed to a methionine residue using
site-directed mutagenesis. The resulting protein is referred to as
HEL308K365M. For a number of ATPases, including
E. coli UvrD and S. cerevisiae Rad3, mutation of
the equivalent lysine residue severely impairs nucleotide triphosphate
hydrolysis, although the overall structure of the protein seems to
remain intact (21-23).
For protein production, both cDNAs were placed under the
transcriptional control of the polyhedrin promoter in recombinant baculoviruses. These viruses were used to transfect Sf9 cells. The proteins HEL308 and HEL308K365M were detected in cell
extracts by immunoblotting (data not shown). The extract was
fractionated over a Ni2+-nitrilotriacetate superflow resin
(Qiagen), a Mono Q column, and a Mono S column, and samples of the
HEL308-containing fractions were analyzed by electrophoresis through an
SDS-polyacrylamide gel (Fig. 2). A sample
of the final purification step of the HEL308K365M protein,
which was produced and purified in exactly the same manner as the wild
type protein, is shown in Fig. 2, lane 5.
ATPase and Helicase Activity of Human HEL308--
To characterize
human HEL308, helicase and ATPase assays were performed on fractions
along the Mono Q column gradient. Human HEL308 co-fractionated with a
helicase activity and an ATPase activity (Fig.
3), though protein eluting after the peak
fraction may be in a less active form. The helicase assay tested the
ability to displace a 24-nt oligonucleotide from M13mp18 viral DNA
(Fig. 3B). In the ATPase assay, released radiolabeled
phosphate was separated from non-hydrolyzed ATP by thin layer
chromatography, and the extent of hydrolysis was quantified (Fig.
3C). This ATPase activity was dependent upon the addition of
single-stranded DNA to the reaction mixture, as found for other related
enzymes (24).
Human HEL308 was further purified through a Mono S column. HEL308
ATPase activity was strongly stimulated by single-stranded DNA but not
by double-stranded plasmid DNA (Fig.
4A). Unwinding of the 40-bp
partial duplex substrate catalyzed by HEL308 required a nucleotide
cofactor (Fig. 4B), as expected. Substituting 4 mM Mn2+ instead of Mg2+ gave barely
detectable helicase activity (Fig. 4B, lane 1). A non-hydrolyzable ATP analog, AMP-PNP, could not support the helicase activity (Fig. 4B, lane 2). To determine whether
nucleotide hydrolysis was needed for helicase activity, increasing
amounts of AMP-PNP or ATP
To determine the nucleotide preference of HEL308, eight nucleotides
were tested for their ability to support unwinding of the 40-bp partial
duplex substrate. At the 2 mM nucleotide concentration used, only ATP and dATP gave detectable activity with 76% displacement in the presence of dATP and 33% displacement with ATP (Fig.
4B). ATP was used in further experiments since the ATP
concentration in the cell is higher than the dATP concentration.
Unwinding of Longer DNA Duplexes by HEL308--
To determine
whether HEL308 can unwind longer DNA duplexes, similar DNA substrates
were constructed containing 60- or 70-nt fragments annealed to M13mp18.
DNA helicase assays were performed with each DNA substrate in the
presence of increasing amounts of HEL308 (Fig.
5). The mutant HEL308K365M
could displace none of the substrates (Fig. 5, lanes 3, A-F) and had no ATPase activity (not shown),
confirming that these catalytic activities are due to wild type HEL308
enzyme. The HEL308 helicase displaced both the 60- and the 70-nt
fragments, although with much less efficiency than the 20- and 40-nt
fragments. After 30 min, 1.4 nM HEL308 displaced 89, 32, 2.6, and 2.5% of the 20-, 40-, 60-, and 70-nt oligonucleotides,
respectively.
Substrates with 3'- or 5'-unpaired flaps were also tested. A
non-complementary stretch of (A)10 was added either 5' or
3' of the 40-nt fragment (Fig. 5, C and D). In
neither case was unwinding activity changed, as compared with the
displacement of the 40-nt fragment (Fig. 5G). We followed
the unwinding reaction of the 20-bp partial duplex substrate at
different time points using 0.14 nM HEL308 (Fig.
5H). After 10 min, 20% of the substrate was unwound with
50% unwinding reached after 18 min. The percentage of unwound
substrate increased further with time.
Single-stranded DNA-binding Protein RPA Stimulates the HEL308
Helicase--
One possible reason for the fact that the HEL308
helicase is less efficient in unwinding DNA duplexes of increasing
length might be that the displaced single strand tends to re-anneal. If
this is the case, the activity of HEL308 might be stimulated by
single-stranded DNA-binding proteins. To test this possibility, the
helicase activity was measured in the presence of purified human RPA
(Fig. 6). In reactions containing the
annealed 70-nt fragment and 2.8 nM HEL308, RPA stimulated
HEL308 helicase activity with maximal stimulation at ~2
nM RPA. At this concentration, RPA increased displacement
of the 70-nt fragment by 2.6-fold. 7.5 nM RPA did not
stimulate HEL308 helicase activity (Fig. 6, lane 8), and
concentrations of RPA equal or higher than 15 nM inhibited
its activity (data not shown). These results suggest that RPA
stimulates HEL308 by binding to the unwound regions produced by HEL308
helicase activity and inhibiting re-annealing. Given a binding site of
about 30 nt for human RPA (28), 15 nM RPA covers
approximately 25% of the M13 single-stranded DNA annealed to the 70-nt
fragment. This concentration of RPA may more likely inhibit HEL308
translocation on DNA rather than its binding to DNA. The order of
addition of RPA and HEL308 did not affect these results (data not
shown).
The HEL308 Helicase Acts in the 3' to 5' Direction--
To
determine the polarity of the HEL308 helicase ,the 60-nt
oligonucleotide was annealed to M13mp18 DNA, cut with SalI,
and labeled at the 3'-ends with 32P. This produced linear
M13mp18 DNA with a 20-nt fragment annealed to its 5'-end and a 44-nt
fragment annealed to its 3'-end. HEL308 displaced only the 20-nt
fragment, indicating translocation in the 3' to 5' direction (Fig.
7A). Because HEL308 helicase
activity decreases as a function of the size of the annealed
oligonucleotide that it has to displace, a second DNA substrate was
prepared. In this case, 42- and 32-nt fragments were annealed at the
5'- and 3'-end of linear M13mp18 DNA, respectively. HEL308 helicase activity displaced only the 42-nt fragment (Fig. 7B). These
results confirm that the polarity of the HEL308 helicase is 3' to 5'
relative to the single-stranded region.
Gel Filtration Analysis of Human HEL308--
The oligomeric
structure of a DNA helicase is an important parameter that may have
implications for its mechanism of action (29). The native molecular
weight of human HEL308 was estimated from gel filtration analysis.
Fraction 28 of the Mono Q column was loaded onto a Superose column
equilibrated in buffer that included 0.5 M KCl. Proteins
were eluted, and fractions were analyzed. Immunoblotting, ATPase, and
helicase activities all co-eluted at a position corresponding to a
molecular size of ~600 kDa as determined from standards (Fig.
8). This would be consistent with a
possible hexameric association given the predicted molecular size of
124 kDa for a HEL308 monomer. Under the same gel filtration conditions,
the mutant HEL308K365M protein eluted at the same position
as wild type HEL308 as determined by immunoblotting (not shown). This
suggests that the point mutation K365M in the Walker A motif does not
alter the quaternary structure of the protein.
We isolated human and mouse homologs of the helicase domain of
D. melanogaster mus308 and designated them HEL308.
Drosophila mus308 encodes a DNA polymerase in its C-terminal
portion and a DNA helicase in its N-terminal portion (11). We found
homologs of Drosophila mus308 in C. elegans and
A. thaliana in addition to those in human and mouse, but we
could not find any homolog in S. cerevisiae or in other
yeast and bacterial species. The presumably full-length cDNA for
human POLQ also has a predicted helicase domain at the N
terminus, but its activity remains to be demonstrated.
The MUS308 family of helicases is part of the superfamily II of
DNA and RNA helicases. Harris et al. (11) identified other sequences in GenBankTM that have sequence similarity to the
helicase domain of Drosophila mus308. Besides the seven
characteristic motifs of the superfamily II, these putative helicases
include motifs Ib and IVa containing characteristic residues in the
MUS308 subfamily. Motif I (the Walker A box) is unusual in having a
serine in place of the glycine found in almost all Walker A motifs of
known or putative helicases (Fig. 1, asterisk). Other
residues, shown with an asterisk in Fig. 1, are peculiar to
the MUS308 family of helicases: in motif V, the threonine is usually a
hydrophobic residue in other members of superfamily II; in motif VI,
the methionine is on the contrary usually a charged residue. Moreover,
the MUS308 subfamily seems to combine motifs from various families.
Motif II is characteristic of the so-called DEXH family of helicases,
which includes many "repair/recombination" helicases, such as Rad3,
Rad54, WRN, and BLM, whereas motif IV has characteristics of the DEAD
family of RNA helicases.
HEL308 is a single-stranded DNA-dependent ATPase and DNA
helicase. It translocates on DNA with 3' to 5' polarity and efficiently displaces 20- to 40-mer duplex oligonucleotides. Although activity on
longer substrates is lower, it can be stimulated by the single-stranded DNA-binding protein RPA. Other helicases have been shown to be stimulated by single-stranded DNA-binding proteins. For example, S. cerevisiae MER3 helicase efficiently unwinds a 631-nt
fragment only in the presence of RPA (30). Substrates with 3'- or
5'-unpaired flaps do not stimulate HEL308 activity, whereas many
helicases, such as E. coli DnaB, phage T4 gene 41 protein,
and phage T7 gene 4 protein, require a forked DNA substrate to initiate
DNA unwinding in vitro (29). WRN helicase displaces a 40-nt
oligonucleotide much more efficiently when two unpaired 10-mers are
added to the 40-mer at its 3'- and 5'-ends (31). Both BLM and WRN
prefer a fork DNA substrate to unwind DNA (32). Gel filtration analysis suggests that HEL308 behaves as a multimer, possibly a hexamer. A few
DNA helicases studied to date operate as monomers, such as PcrA (33)
and T4 Dda helicase (34). Many more helicases are active as oligomers,
often as hexamers (T7 gene 4, T4 gp41, E. coli DnaB, and
BLM) or dimers (E. coli Rep helicase) (29, 35). Studies by
electron microscopy will reveal whether HEL308 forms multimeric structures.
Drosophila mus308 is believed to be involved in the repair
of interstrand DNA cross-linking damage since mus308 mutants
are hypersensitive to DNA cross-linking agents such as photoactivated psoralen, diepoxybutane, and nitrogen mustard but are not sensitive to
the monofunctional alkylating agent methyl methanesulfonate (11). Not
much is known about how interstrand cross-links are repaired in
eukaryotes. Biochemical and genetic analyses in prokaryotes indicate
that DNA interstrand cross-links are repaired by an
excision-recombination mechanism (36, 37). In E. coli,
removal of a DNA interstrand cross-link is initiated by the UvrABC
endonuclease complex, which incises one strand on each side of the
cross-link. The 5' nuclease activity of DNA polymerase I, in concert
with the UvrD helicase, generates a gap at the site of incision. The
resulting single-stranded region provides a substrate for binding of
RecA protein and for the initiation of homologous pairing and strand
exchange. The polymerase activity of DNA polymerase I can then carry
out repair synthesis with an undamaged homolog as a template. Some
aspects of this mechanism of interstrand cross-link repair may be
conserved in eukaryotes. Genetic data suggest that both excision and
recombination are involved in the repair of interstrand cross-links in
eukaryotes as well. Mus308 and POLQ belong to the A family of DNA
polymerases, as does E. coli DNA polymerase I. Both UvrD and
HEL308 are 3' to 5' multimeric DNA helicases. This direction of
translocation along DNA would fit a model where coupling between a
helicase and a polymerase coordinates duplex unwinding and
polymerization. Gene 4 of bacteriophage T7 encodes a protein (gp4) that
has both a helicase and an RNA primase domain. gp4 forms hexameric
rings that can translocate along single-stranded DNA, coupling the
unwinding of duplex DNA with the synthesis of short RNA primers that
are elongated by T7 DNA polymerase (38). It will be interesting to
analyze whether HEL308 interacts with a polymerase and forms a complex
with an activity similar to T7 gp4. The existence of both HEL308 and
the very similar putative helicase of POLQ raises further questions
concerning the functions of these enzymes. It is possible that they
function in DNA repair processes in different tissues.
Fanconi anemia cell lines are sensitive to interstrand cross-linking
agents. Thus far, eight Fanconi anemia complementation groups have been
defined, and six genes have been mapped and cloned (1). We are
currently investigating the possibility that HEL308 might be
one of the two remaining uncloned genes, FANCB and
FANCD1.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-32P]ATP (specific activity > 5000 Ci/mmol),
1.4 nM HEL308 or 1.4 nM HEL308K365M
protein. Incubations were for 60 min at 30 °C. Reactions were terminated by the addition of 5 µl of 0.5 M EDTA.
Released phosphate was separated from ATP by thin-layer chromatography
on polyethyleneimine cellulose using 0.75 M
KH2PO4 as the running buffer. Hydrolysis was
quantified with the use of a Fuji phosphorimaging device.
-32P]ATP and annealed to
M13mp18 viral DNA. For determination of polarity, 60- and 70-mer
oligonucleotides were annealed to M13mp18, and the duplex portion was
cut with SalI and labeled with DNA polymerase I (Klenow
fragment), 15 µM cold dTTP, and 20 µCi
[
-32P]dCTP. Labeled substrates were separated from
labeled oligonucleotides with MobiSpin Sephacryl S-400 columns
(MoBiTec). Unless otherwise specified, standard reaction mixtures
contained 50 mM KCl, 20 mM Tris-HCl, pH 7.5, 4 mM MgCl2, 1 mM dithiothreitol, 50 µg/ml bovine serum albumin, 2 mM ATP, and ~6 fmol of
substrate in a 20-µl volume. Human RPA was produced as a recombinant
protein in E. coli, purified according to the method of
Henricksen et al. (20), and included where indicated.
Incubation was for 30 min at 37 °C. Reactions were terminated by the
addition of 6 µl of gel loading buffer (0.25% bromphenol blue,
0.25% xylene cyanol, 30% glycerol, and 0.17 M EDTA). DNA
species were separated by electrophoresis through non-denaturing 10%
polyacrylamide gels that were dried and analyzed by autoradiography or
quan- tified with a Fuji phosphorimaging device.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (109K):
[in a new window]
Fig. 1.
Sequence alignment of human and mouse HEL308
with A. thaliana MUS308, human POLQ,
D. melanogaster Mus308, and C. elegans
MUS-1 and with human WRN and BLM DNA helicases and E. coli Dead RNA helicase. Roman numerals
indicate regions conserved in DNA and RNA helicases, and the
bars mark their approximate extent. The arrow
indicates the lysine that was mutated to methionine in mutant
HEL308K365M. Positions with six or more identical residues
are shaded. The asterisks denote residues that
are conserved in the MUS308 subfamily of helicases but not in other
known or putative helicases. The sequence alignment was carried out
using the Clustal X program.

View larger version (71K):
[in a new window]
Fig. 2.
Purification of human HEL308 protein. A
silver-stained SDS-polyacrylamide gel containing samples taken
at different stages of the HEL308 purification is shown. A protein
extract from Sf9 cells infected with a baculovirus expressing
human HEL308 was fractionated sequentially over
Ni2+-nitrilotriacetate (Ni-NTA) superflow resin
(lane 2), Mono Q (lane 3), and Mono S (lane
4) columns. The HELK365M protein was purified by the
same method, and a sample of the final preparation is shown in
lane 5. Lanes 2-5 contain ~0.34 µg of
protein. M, broad range molecular weight markers (Bio-Rad
Laboratories).

View larger version (66K):
[in a new window]
Fig. 3.
ATPase and DNA helicase activities of
HEL308. Recombinant HEL308 was fractionated on a Mono Q column.
A, immunoblot using His Tag Monoclonal Antibody (Novagen).
B, DNA helicase assay using a 24-nt oligomer annealed to M13
viral DNA as a substrate. Oligonucleotide was labeled with
32P at the 5'-end before annealing to the viral DNA. DNA
substrate (~6 fmol) was incubated with 5 µl from different
fractions along the Mono Q gradient in the presence of ATP for 30 min
at 37 °C. Products were separated by electrophoresis through a
non-denaturing polyacrylamide gel and visualized by autoradiography.
The positions of the substrate and the radiolabeled reaction products
are indicated to the left of the autoradiogram. The
asterisk denotes the position of the 32P label.
First lane, substrate incubated in the helicase buffer in
the absence of any protein fraction. Lane B, boiled
substrate. C, ATPase assay in the presence (+ ssDNA) or absence (
ssDNA) of 100 ng of M13mp18
single-stranded DNA.
S were added to reaction mixtures that
contained 2 mM ATP (Fig. 4C). AMP-PNP at 10 mM and ATP
S at 2 mM were competitive inhibitors of helicase action, indicating that they bind to HEL308 in
place of ATP and that nucleotide hydrolysis is necessary for activity.
The result also suggests that ATP
S has a higher affinity for HEL308
nucleotide binding sites than AMP-PNP. Drosophila RecQ5 helicase activity is similarly inhibited by an equimolar ratio of
ATP
S to ATP but not by an equimolar ratio of AMP-PNP to ATP (25).
Interestingly, 2-4 mM AMP-PNP stimulated unwinding
activity by about 2-fold in the presence of 2 mM ATP. This
may suggest cooperative binding to an enzyme that has both catalytic
and noncatalytic nucleotide binding sites, as found for the hexameric
T7 gene 4 and E. coli Rho helicases (26, 27). T7 gene 4 helicase prefers dTTP as a nucleotide cofactor, and the
non-hydrolyzable nucleotide analog dTMP-PCP can bind to a noncatalytic
site with little effect on dTTPase turnover (27).

View larger version (27K):
[in a new window]
Fig. 4.
Nucleotide and DNA cofactors for HEL308
activity. A, ATPase assay. 0.1 mM ATP and
0.25 µCi of [
-32P]ATP were incubated with 1.4 nM HEL308 (lanes 2-4) in the presence of 100 ng
of M13 single-stranded DNA (ssDNA, lane 3) or 100 ng of pGEM-3Z double-stranded DNA (dsDNA, lane
4). Reactions were for 60 min at 30 °C. Released phosphate was
separated from ATP by thin-layer chromatography on polyethyleneimine
cellulose. B, helicase reaction mixtures contained the 40-bp
partial duplex substrate, 1.4 nM HEL308, 50 mM
KCl, 4 mM MgCl2, and 2 mM of the
indicated nucleotides in a 20-µl volume. Incubation was for 30 min at
37 °C. In the first lane, MgCl2 was omitted,
and 4 mM MnCl2 used instead. The nucleotide
cofactor was ATP. Radioactivity was quantified with the use of a Fuji
phosphorimaging device, and the percentage of displaced radioactivity
is shown under each lane of the autoradiogram. C,
helicase reaction mixtures contained the 40-bp partial duplex
substrate, 1.4 nM HEL308, 50 mM KCl, 4 mM MgCl2, 2 mM ATP, and the
indicated amount of either AMP-PNP or ATP
S in a 20-µl volume. In
the lanes where AMP-PNP and ATP
S were added, additional
MgCl2 was also added at equimolar concentration. In the
first two lanes, no protein was added. Lane B,
boiled substrate.

View larger version (29K):
[in a new window]
Fig. 5.
Unwinding reactions on different DNA
substrates catalyzed by HEL308. The unwinding activity of
HEL308 DNA helicase was evaluated with six different substrates and
increasing amounts of the protein HEL308 (A-F).
A schematic diagram of the structure of each substrate is shown on the
left of each autoradiogram. In the first two
lanes, no protein was added. Lane B, boiled substrate.
In the third lane, K365M mutant protein was added at a
concentration of 2.8 nM. Remaining lanes,
increasing amounts of purified HEL308 (in nM). G, plot of
fragment displacement (%). Each point is the mean value of three
different experiments. H, displacement of the 20-nt fragment
from M13mp18 viral DNA at different times with 0.14 nM
HEL308. In the first two lanes, no protein was added.
Lane B, boiled substrate.

View larger version (70K):
[in a new window]
Fig. 6.
RPA Stimulates displacement of the 70-nt
fragment. Displacement of the 5'-end-labeled 70-nt fragment
annealed to M13mp18 single-stranded DNA was examined in the presence of
increasing amounts of human RPA. Reaction mixtures contained ~6 fmol
of DNA substrate. In the first two lanes, no protein was
added. Lane B, boiled substrate. Remaining lanes,
2.8 nM purified HEL308 was added together with increasing
amounts of RPA.

View larger version (32K):
[in a new window]
Fig. 7.
Unwinding of DNA duplexes flanking a
single-stranded region. The DNA substrate was an
~7100-nt-long single-stranded region flanked by labeled duplexes as
shown on the right of each autoradiogram. Lane B,
boiled substrate;
, no protein added; +, 2.8 nM HEL308.
In panel B, first lane, the band intermediate
between the 32- and 42-nt fragments is derived from limited extension
of the 32-mer with DNA polymerase. Pol I, DNA polymerase
I.

View larger version (29K):
[in a new window]
Fig. 8.
Gel filtration analysis of native
HEL308. Fractionation of human HEL308 on a Superose column.
A, immunoblot using His Tag Monoclonal Antibody (Novagen).
Lane L contained 10 µl of fraction number 28 from the Mono
Q elution (~0.3 M KCl) that was loaded onto the Superose
column; the remaining lanes contained 10 µl of the
indicated fractions. Gel filtration standards (Amersham Biosciences,
Inc.) were as follows: thyroglobulin (669 kDa), ferritin (440 kDa),
catalase (232 kDa), aldolase (158 kDa), and albumin (67 kDa).
B, displacement of a 20-nt fragment from M13mp18
single-stranded DNA by 10 µl of the indicated fractions.
C, plot of protein concentration (immunoblot), percentage of
displaced 20-nt fragment (helicase assay), and percentage of released
phosphate (ATPase assay) for each fraction. Protein concentration on
the immunoblot was quantified with the ChemiDoc chemiluminescence
detection system (Bio-Rad Laboratories). Displaced radioactivity was
quantified with the Fuji phosphorimaging device.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. G. Sebastiaan Winkler for assistance and our laboratory colleagues for discussions.
| |
FOOTNOTES |
|---|
* This work was supported by postdoctoral fellowships from the European Molecular Biology and from Telethon (to F. M.), by the Imperial Cancer Research Fund, and by the University of Pittsburgh Cancer Institute.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AF436845 and AF436846.
To whom correspondence should be addressed: S867 Scaife
Hall, 3550 Terrace St., Pittsburgh, PA 15261. Tel: 412-648-9248; Fax: 412-383-9822; E-mail: rdwood@pitt.edu.
Published, JBC Papers in Press, December 18, 2001, DOI 10.1074/jbc.M110271200
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
ICL, interstrand cross-link;
RACE, rapid amplification of cDNA ends;
AMP-PNP, adenylyl-imidodiphosphate tetralithium salt;
ATP
S, adenosine-5'-O-(3-thiotriphosphate);
nt, nucleotides;
dTMP-PCP,
,
-methylene deoxythymidine triphosphate.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Dronkert, M. L., and Kanaar, R. (2001) Mutat. Res. 486, 217-247[Medline] [Order article via Infotrieve] |
| 2. |
Magana-Schwencke, N.,
Henriques, J. A.,
Chanet, R.,
and Moustacchi, E.
(1982)
Proc. Natl. Acad. Sci. U. S. A.
79,
1722-1726 |
| 3. | Lawley, P. D., and Phillips, D. H. (1996) Mutat. Res. 355, 13-40[CrossRef][Medline] [Order article via Infotrieve] |
| 4. |
De Silva, I. U.,
McHugh, P. J.,
Clingen, P. H.,
and Hartley, J. A.
(2000)
Mol. Cell. Biol.
20,
7980-7990 |
| 5. |
Van Houten, B.
(1990)
Microbiol. Rev.
54,
18-51 |
| 6. |
Cole, R. S.
(1973)
Proc. Natl. Acad. Sci. U. S. A.
70,
1064-1068 |
| 7. | Jachymczyk, W. J., von Borstel, R. C., Mowat, M. R., and Hastings, P. J. (1981) Mol. Gen. Genet. 182, 196-205[CrossRef][Medline] [Order article via Infotrieve] |
| 8. |
Hoy, C.,
Thompson, L.,
Mooney, C.,
and Salazar, E.
(1985)
Cancer Res.
45,
1737-1743 |
| 9. | Thompson, L. F. (1996) Mutat. Res. 363, 77-88[Medline] [Order article via Infotrieve] |
| 10. | Boyd, J. B., Sakaguchi, K., and Harris, P. V. (1990) Genetics 125, 813-819[Abstract] |
| 11. | Harris, P. V., Mazina, O. M., Leonhardt, E. A., Case, R. B., Boyd, J. B., and Burtis, K. C. (1996) Mol. Cell. Biol. 16, 5764-5771[Abstract] |
| 12. | Sharief, F. S., Vojta, P. J., Ropp, P. A., and Copeland, W. C. (1999) Genomics 59, 90-96[CrossRef][Medline] [Order article via Infotrieve] |
| 13. |
Yoakum, G. H.,
and Cole, R. S.
(1977)
J. Biol. Chem.
252,
7023-7030 |
| 14. | Ellis, N. A., Groden, J., Ye, T.-Z., Straughen, J., Lennon, D. J., Ciocci, S., Proytcheva, M., and German, J. (1995) Cell 83, 655-666[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Gray, M. D., Shen, J. C., Kamath-Loeb, A. S., Blank, A., Sopher, B. L., Martin, G. M., Oshima, J., and Loeb, L. A. (1997) Nat. Genet. 17, 100-103[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Kitao, S., Lindor, N. M., Shiratori, M., Furuichi, Y., and Shimamoto, A. (1999) Genomics 61, 268-276[CrossRef][Medline] [Order article via Infotrieve] |
| 17. |
Lindahl, T.,
and Wood, R. D.
(1999)
Science
286,
1897-1905 |
| 18. | Köberle, B., Grimaldi, K. A., Sunters, A., Hartley, J. A., Kelland, L. R., and Masters, J. R. (1997) Int. J. Cancer 70, 551-555[CrossRef][Medline] [Order article via Infotrieve] |
| 19. | Vilpo, J. A., Vilpo, L. M., Szymkowski, D. E., O'Donovan, A., and Wood, R. D. (1995) Mol. Cell. Biol. 15, 290-297[Abstract] |
| 20. |
Henricksen, L.,
Umbricht, C.,
and Wold, M.
(1994)
J. Biol. Chem.
269,
11121-11132 |
| 21. | Sung, P., Higgins, L., Prakash, L., and Prakash, S. (1988) EMBO J. 7, 3263-3269[Medline] [Order article via Infotrieve] |
| 22. | George, J. W., Brosh, R. M., Jr., and Matson, S. W. (1994) J. Mol. Biol. 235, 424-435[CrossRef][Medline] [Order article via Infotrieve] |
| 23. |
Winkler, G. S.,
Vermeulen, W.,
Coin, F.,
Egly, J. M.,
Hoeijmakers, J. H. J.,
and Weeda, G.
(1998)
J. Biol. Chem.
273,
1092-1098 |
| 24. | Matson, S. W., Bean, D. W., and George, J. W. (1994) Bioessays 16, 13-22[CrossRef][Medline] [Order article via Infotrieve] |
| 25. |
Özsoy, A. Z.,
Sekelsky, J. J.,
and Matson, S. W.
(2001)
Nucleic Acids Res.
29,
2986-2993 |
| 26. |
Kim, D. E.,
Shigesada, K.,
and Patel, S. S.
(1999)
J. Biol. Chem.
274,
11623-11628 |
| 27. |
Hingorani, M. M.,
Washington, M. T.,
Moore, K. C.,
and Patel, S. S.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
5012-5017 |
| 28. |
Bastin-Shanower, S. A.,
and Brill, S. J.
(2001)
J. Biol. Chem.
276,
36446-36453 |
| 29. | Lohman, T. M., and Bjornson, K. P. (1996) Annu. Rev. Biochem. 65, 169-214[CrossRef][Medline] [Order article via Infotrieve] |
| 30. |
Nakagawa, T.,
Flores-Rozas, H.,
and Kolodner, R. D.
(2001)
J. Biol. Chem.
276,
31487-31493 |
| 31. |
Suzuki, N.,
Shimamoto, A.,
Imamura, O.,
Kuromitsu, J.,
Kitao, S.,
Goto, M.,
and Furuichi, Y.
(1997)
Nucleic Acids Res.
25,
2973-2978 |
| 32. |
Mohaghegh, P.,
Karow, J. K.,
Brosh, R. M., Jr.,
Bohr, V. A.,
and Hickson, I. D.
(2001)
Nucleic Acids Res.
29,
2843-2849 |
| 33. | Velankar, S. S., Soultanas, P., Dillingham, M. S., Subramanya, H. S., and Wigley, D. B. (1999) Cell 97, 75-84[CrossRef][Medline] [Order article via Infotrieve] |
| 34. |
Morris, P. D.,
Tackett, A. J.,
Babb, K.,
Nanduri, B.,
Chick, C.,
Scott, J.,
and Raney, K. D.
(2001)
J. Biol. Chem.
276,
19691-19698 |
| 35. | Karow, J. K., Newman, R. H., Freemont, P. S., and Hickson, I. D. (1999) Curr. Biol. 9, 597-600[CrossRef][Medline] [Order article via Infotrieve] |
| 36. |
Cheng, S.,
Van Houten, B.,
Gamper, H. B.,
Sancar, A.,
and Hearst, J. E.
(1988)
J. Biol. Chem.
263,
15110-15117 |
| 37. |
Sladek, F. M.,
Munn, M. M.,
Rupp, W. D.,
and Howard-Flanders, P.
(1989)
J. Biol. Chem.
264,
6755-6765 |
| 38. | VanLoock, M. S., Chen, Y. J., Yu, X., Patel, S. S., and Egelman, E. H. (2001) J. Mol. Biol. 311, 951-956[CrossRef][Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
J. D. Richards, K. A. Johnson, H. Liu, A.-M. McRobbie, S. McMahon, M. Oke, L. Carter, J. H. Naismith, and M. F. White Structure of the DNA Repair Helicase Hel308 Reveals DNA Binding and Autoinhibitory Domains J. Biol. Chem., February 22, 2008; 283(8): 5118 - 5126. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. McCaffrey, D. St Johnston, and A. Gonzalez-Reyes Drosophila mus301/spindle-C Encodes a Helicase With an Essential Role in Double-Strand DNA Break Repair and Meiotic Progression Genetics, November 1, 2006; 174(3): 1273 - 1285. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Guy and E. L. Bolt Archaeal Hel308 helicase targets replication forks in vivo and in vitro and unwinds lagging strands Nucleic Acids Res., June 30, 2005; 33(11): 3678 - 3690. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Fujikane, K. Komori, H. Shinagawa, and Y. Ishino Identification of a Novel Helicase Activity Unwinding Branched DNAs from the Hyperthermophilic Archaeon, Pyrococcus furiosus J. Biol. Chem., April 1, 2005; 280(13): 12351 - 12358. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Shima, R. J. Munroe, and J. C. Schimenti The Mouse Genomic Instability Mutation chaos1 Is an Allele of Polq That Exhibits Genetic Interaction with Atm Mol. Cell. Biol., December 1, 2004; 24(23): 10381 - 10389. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Laurencon, C. M. Orme, H. K. Peters, C. L. Boulton, E. K. Vladar, S. A. Langley, E. P. Bakis, D. T. Harris, N. J. Harris, S. M. Wayson, et al. A Large-Scale Screen for Mutagen-Sensitive Loci in Drosophila Genetics, May 1, 2004; 167(1): 217 - 231. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cantor, R. Drapkin, F. Zhang, Y. Lin, J. Han, S. Pamidi, and D. M. Livingston The BRCA1-associated protein BACH1 is a DNA helicase targeted by clinically relevant inactivating mutations PNAS, February 24, 2004; 101(8): 2357 - 2362. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Seki, F. Marini, and R. D. Wood POLQ (Pol {theta}), a DNA polymerase and DNA-dependent ATPase in human cells Nucleic Acids Res., November 1, 2003; 31(21): 6117 - 6126. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Marini, N. Kim, A. Schuffert, and R. D. Wood POLN, a Nuclear PolA Family DNA Polymerase Homologous to the DNA Cross-link Sensitivity Protein Mus308 J. Biol. Chem., August 22, 2003; 278(34): 32014 - 32019. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Shima, S. A. Hartford, T. Duffy, L. A. Wilson, K. J. Schimenti, and J. C. Schimenti Phenotype-Based Identification of Mouse Chromosome Instability Mutants Genetics, March 1, 2003; 163(3): 1031 - 1040. [Abstract] [Full Text] [PDF] |
||||
| ||||||